Practice Update | Onology
VOL. 1 • NO. 2 • 2017
OUR EXPERTS. YOUR PRACTICE.
Expert consensus on de-escalating and escalating treatments for early-stage breast cancer
People are going to be looking at abiraterone with a low-dose prednisone, only 5mg of prednisone, add it to ADT as being a new potential standard of care.
Dr Oliver Sartor on the STAMPEDE trial and prostate cancer
Conference ASCO 2017
JOURNAL SCAN Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB)
Risks of breast, ovarian, and contralateral breast cancer for BRCA1- and BRCA2-mutation carriers
Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder cancer
Made with FlippingBook